Published • loading... • Updated
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $5,364,237.12 in Stock
Summary by defenseworld.net
1 Articles
1 Articles
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $5,364,237.12 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) CFO Adam Scott Levy sold 119,524 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $44.88, for a total value of $5,364,237.12. Following the sale, the chief financial officer owned 19,396 shares in the company, valued at $870,492.48. The trade was a 86.04% decrease in their position. The transaction was disclosed in a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium